Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

New Virtual Heart Reveals Important Information on Common Heart Defect

By BiotechDaily International staff writers
Posted on 06 Feb 2013
Print article
Image: Image from the advanced new 3D virtual heart model. (Photo courtesy of University of Manchester).
Image: Image from the advanced new 3D virtual heart model. (Photo courtesy of University of Manchester).
With advanced computational technology and information, researchers have built a highly accurate 3D model of a mammalian heart, enabling a study that revealed new information about the mechanisms underlying one of the world’s most common heart conditions.

In a collaborative effort led by scientists at the University of Manchester (Manchester, UK), the model was developed by taking a series of very thin slices of a sheep’s heart, imaging them in 2D, then computationally rendering them into a 3D virtual model. The anatomically realistic reconstruction includes details of the complex fiber structure of the tissue, and the segmentation of the upper chambers of the heart into known distinctive regions. Single-cell models that take into account information about the electrical activity in different atrial regions were then incorporated into the model. The virtual heart was then used to investigate the sudden irregular heart-rate condition “atrial fibrillation” (AF), which affects approximately 1.5% of the population worldwide, and is known to increase the risk and severity of stroke, yet very little is known about its cause(s).

The research team focused on the pulmonary vein, a common area that triggers AF. They simulated erratic electrical waves passing through the vein and the surrounding atrial tissue, then studied the impact this had on the rest of the heart. Electrical heterogeneity (regional differences in the electrical activity across the heart tissue) was found to be a key to initiation of AF. The largest electrical difference was between the pulmonary vein and the left atrium, which may help explain why the pulmonary vein region is a common source of AF. The scientists also identified that fiber structure plays an important role in the development of AF. There were directional variations in the conduction of electrical waves along and across the fibers, variations known as anisotropy. The fiber structure in the left atrium is much more organized compared with the complex structures of the pulmonary vein region. The sudden variation in conduction at the junction between the left atrium and the pulmonary vein regions appeared to contribute to the development of AF.

“This study has for the first time identified the individual role of electrical heterogeneity and fiber structure in the initiation and development of AF. It has not previously been possible to study the contribution of the two separately, but using our computational model we’ve been able to clearly see that both electrical heterogeneity and fiber structure need to be taken into consideration when treatment strategies for AF are being devised,” explained lead investigator Prof. Henggui Zhang: “We’re really excited about the potential that our virtual heart opens up for research into this incredibly complex organ. By bringing together physics and biology, we hope to unlock some of the unanswered questions about atrial fibrillation, a condition, which is only going to become more common as people live longer. ”

The next step planned for the team is to find a way to target the electrical conduction in specific regions of the heart to better protect against AF.

The study was published online January 16, 2013, in the Royal Society’s independent journal Interface Focus.

Related Links:
University of Manchester


Print article

Channels

Genomics/Proteomics

view channel
Image: A dark field photomicrograph showing the spirochete bacterium Borrelia burgdorferi, the pathogen responsible for causing Lyme disease (Photo courtesy of the CDC).

Statins May Help Block Transmission of Lyme Disease

A recent study found that treatment with cholesterol-lowering statins reduced the number of Borrelia burgdorferi bacteria in rodents, which helped to block transmission of Lyme disease. Lyme disease... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.